Frontlight ResearchEarly access
Trial site
Cambridge
- 11running trials
- 4closed trials
The trials here
What the 15 trials at this site are about, from their registry records.
- Conditions
- ANCA-associated vasculitis2 trials
- Prostate cancer2 trials
- Chronic kidney disease1 trial
- Chronic myeloid leukaemia1 trial
- Colorectal cancer1 trial
- Epilepsy1 trial
- High blood pressure1 trial
- Huntington's disease1 trial
- IgA nephropathy1 trial
- Lupus (SLE)1 trial
- Multiple sclerosis1 trial
- Neuroendocrine tumours1 trial
- and 2 more
- Phase
- Phase 37 trials
- Phase 24 trials
- Phase 42 trials
- Phase 1/21 trial
- Status
- Active, not recruiting7 trials
- Recruiting4 trials
- Completed2 trials
- Terminated2 trials
- Lead sponsor
- Novartis Pharmaceuticals14 trials
- Advanced Accelerator Applications1 trial
Running trials
Recruiting
A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy
Recruiting
Active, not recruiting
Phase 2 Study Evaluating Rapcabtagene Autoleucel in Participants With Severe Active GPA or MPA
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- High blood pressure1 recruiting
- Huntington's disease1 recruiting
- Prostate cancer1 recruiting
- Pulmonary arterial hypertension1 recruiting
Closed trials
Terminated
Terminated
Completed
Recruiting
Site data: ClinicalTrials.govUpdated 17 Nov 2026